The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.

Login to TechFinder » 

Anti-Pknox monoclonal antibody


Stanford Reference:

01-245G


Abstract


Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pknox monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis. The Meis/Pknox (also known as Prep) subfamily of TALE (three-amino acid loop extension)-class homeodomian proteins heterodimerze with Pbx proteins to form trimeric complexes with Hox proteins on appropriate DNA sites that regulate developmental gene expression. The anti-Pknox antibodies could be used in research related to leukemia, embryonic development, and tissue homeostasis.

Applications


  • Research related to:
    • leukemia
    • embryonic development
    • tissue homeostasis

Publications



Web Site


Cleary Lab

Innovators & Portfolio



Date Released

 4/21/2015
 

Licensing Contact


Brenda Martino, Biological Materials Specialist
(650) 725-9119 (Direct)
Login to Request Information

[-] Map/Timeline

78-017 Monoclonal Antibodies: 11-6 anti-Ig-5b, 11-5 anti-I-A (2), 11-4 anti-H-2Kk, 11-3 anti-I-A917), 10-4 anti-Ig-5a, H-12 anti-THY 1.2
79-066 Mouse Anti-Human Hybridomas L243, L17F15
82-008 A Monoclonal Antibody Specific For Mouse Granulocytes

more technologies

Related Keywords


transcription factors   leukemia   research tool   research tool: antibody   research tool: cell line   
 

   

  

Also of Interest...
78-017 Monoclonal Antibodies: 11-6 anti-Ig-5b, 11-5 anti-I-A (2), 11-4 anti-H-2Kk, 11-3 anti-I-A917), 10-4 anti-Ig-5a, H-12 anti-THY 1.2
79-066 Mouse Anti-Human Hybridomas L243, L17F15
82-008 A Monoclonal Antibody Specific For Mouse Granulocytes

Recently Viewed...
S01-245G Anti-Pknox monoclonal antibody